1-161624634-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001244753.2(FCGR3B):c.583G>A(p.Ala195Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000237 in 1,603,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001244753.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCGR3B | NM_001244753.2 | c.583G>A | p.Ala195Thr | missense_variant | 5/5 | ENST00000650385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCGR3B | ENST00000650385.1 | c.583G>A | p.Ala195Thr | missense_variant | 5/5 | NM_001244753.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000121 AC: 18AN: 148964Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 247026Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133674
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1454218Hom.: 0 Cov.: 32 AF XY: 0.00000415 AC XY: 3AN XY: 723556
GnomAD4 genome AF: 0.000127 AC: 19AN: 149080Hom.: 0 Cov.: 30 AF XY: 0.000138 AC XY: 10AN XY: 72710
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.583G>A (p.A195T) alteration is located in exon 6 (coding exon 5) of the FCGR3B gene. This alteration results from a G to A substitution at nucleotide position 583, causing the alanine (A) at amino acid position 195 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at